Share Price and Basic Stock Data
Last Updated: January 14, 2026, 9:24 pm
| PEG Ratio | -1.56 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mukand Ltd operates in the steel alloys and special alloys sector, with a current market capitalization of ₹1,875 Cr. The company’s revenue from operations for the financial year ending March 2023 stood at ₹5,568 Cr, a significant increase from ₹4,643 Cr in the previous year. However, the revenue is projected to decline to ₹4,890 Cr for FY 2025, reflecting a downward trend despite a robust performance in recent quarters. Quarterly sales peaked at ₹1,462.44 Cr in September 2022 but have seen fluctuations, with the latest reported sales for September 2023 at ₹1,376.68 Cr. The revenue growth trajectory indicates potential challenges in maintaining consistency in sales, which may stem from pricing pressures or demand fluctuations in the steel market. Mukand’s operating profit margin (OPM) has remained relatively low, with a reported OPM of 5.96% for FY 2025, suggesting that the company faces competitive pressure in managing costs and pricing strategies compared to sector peers.
Profitability and Efficiency Metrics
Mukand Ltd’s profitability metrics have shown volatility, particularly evident in its operating profit (OP) which recorded a loss of ₹378.51 Cr in March 2023. However, the company rebounded with an OP of ₹293 Cr in FY 2024 and ₹285 Cr projected for FY 2025. The return on equity (ROE) stood at 7.84%, while the return on capital employed (ROCE) was at 9.91%, indicating moderate efficiency in generating returns on shareholders’ equity and capital. The interest coverage ratio (ICR) of 2.30x suggests that Mukand is capable of covering its interest obligations, although it remains vulnerable to fluctuations in interest rates or operational performance. The cash conversion cycle (CCC) of 201 days indicates potential inefficiencies in working capital management, as it exceeds typical industry standards, which usually range between 60 to 120 days. This prolonged cycle may impact liquidity and operational agility, necessitating better inventory and receivables management.
Balance Sheet Strength and Financial Ratios
Mukand’s balance sheet reveals a total borrowing of ₹1,811 Cr against reserves of ₹813 Cr, leading to a total debt-to-equity ratio of 1.64x. This level of leverage is relatively high compared to industry norms, which typically do not exceed 1.5x, indicating potential financial risk. The company’s fixed assets stood at ₹539 Cr, reflecting a slight increase from ₹488 Cr in the previous fiscal year, hinting at ongoing capital investments. The book value per share increased to ₹65.71, up from ₹63.74, which is a positive sign for shareholders. However, the current ratio of 1.12x indicates a tighter liquidity position, as it is just above the benchmark of 1.0, suggesting that the company may face challenges in meeting short-term obligations. The enterprise value (EV) of ₹2,833.74 Cr and EV/EBITDA ratio of 9.49x suggests that Mukand is trading at a reasonable valuation compared to its earnings before interest, taxes, depreciation, and amortization.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mukand Ltd reflects a strong promoter holding of 74.70%, which provides a sense of stability and confidence to investors. Institutional ownership is low, with foreign institutional investors (FIIs) at 0.18% and domestic institutional investors (DIIs) at 1.10%, indicating limited external institutional interest. The public holding accounts for 24.01%, with the total number of shareholders increasing to 51,390, which may indicate growing retail investor interest. However, the low FII participation may limit the stock’s liquidity and potential for price appreciation. The dividend payout ratio has seen an upward trend, reaching 38.08% for FY 2025, which is a positive indicator of the company’s commitment to returning value to shareholders. Nevertheless, the reliance on a concentrated promoter stake may pose risks in terms of governance and decision-making, especially during challenging market conditions.
Outlook, Risks, and Final Insight
The outlook for Mukand Ltd presents a mix of opportunities and risks. On the one hand, the company has demonstrated resilience in revenue growth and profitability recovery following a challenging period. However, the anticipated revenue decline and high debt levels pose significant risks to its financial stability. The prolonged cash conversion cycle may hinder operational efficiency and liquidity, necessitating immediate attention to working capital management. The low institutional interest could also impact the stock’s market performance. Moving forward, Mukand may need to focus on improving operational efficiencies, enhancing cash flow management, and potentially diversifying its product offerings to mitigate risks associated with market volatility. If the company can successfully navigate these challenges, it may position itself for sustainable growth, leveraging its established market presence in the alloys and steel sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Elango Industries Ltd | 4.11 Cr. | 10.8 | 16.1/8.45 | 9.72 | 0.00 % | 5.67 % | 5.67 % | 10.0 | |
| Ashnisha Industries Ltd | 98.1 Cr. | 3.70 | 4.94/2.57 | 338 | 2.30 | 0.00 % | 1.23 % | 0.28 % | 1.00 |
| Usha Martin Ltd | 13,233 Cr. | 434 | 498/279 | 31.4 | 97.3 | 0.69 % | 18.8 % | 15.8 % | 1.00 |
| Shah Alloys Ltd | 137 Cr. | 69.0 | 83.8/43.3 | 5.18 | 0.00 % | 25.8 % | 1,108 % | 10.0 | |
| Mukand Ltd | 1,875 Cr. | 130 | 162/84.4 | 29.0 | 66.3 | 1.54 % | 9.91 % | 7.84 % | 10.0 |
| Industry Average | 20,178.00 Cr | 240.25 | 105.53 | 66.63 | 0.44% | 13.27% | 192.30% | 5.67 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,462.44 | 1,330.47 | 1,312.35 | 1,382.29 | 1,376.68 | 1,176.68 | 1,239.16 | 1,257.99 | 1,262.84 | 1,262.27 | 1,106.89 | 1,128.71 | 1,160.62 |
| Expenses | 1,424.46 | 1,255.93 | 1,690.86 | 1,305.32 | 1,306.76 | 1,114.43 | 1,156.31 | 1,187.24 | 1,186.76 | 1,190.00 | 1,041.76 | 1,081.46 | 1,091.48 |
| Operating Profit | 37.98 | 74.54 | -378.51 | 76.97 | 69.92 | 62.25 | 82.85 | 70.75 | 76.08 | 72.27 | 65.13 | 47.25 | 69.14 |
| OPM % | 2.60% | 5.60% | -28.84% | 5.57% | 5.08% | 5.29% | 6.69% | 5.62% | 6.02% | 5.73% | 5.88% | 4.19% | 5.96% |
| Other Income | 22.10 | 6.73 | 553.69 | 2.93 | 3.48 | 5.70 | 3.92 | 4.03 | 3.31 | 1.54 | 5.55 | 38.68 | 2.76 |
| Interest | 45.50 | 51.12 | 37.52 | 33.42 | 33.08 | 33.55 | 31.42 | 31.93 | 32.58 | 31.83 | 33.29 | 33.89 | 37.53 |
| Depreciation | 11.98 | 14.38 | 14.82 | 12.46 | 12.47 | 12.49 | 12.30 | 11.19 | 13.62 | 12.66 | 13.26 | 14.37 | 14.50 |
| Profit before tax | 2.60 | 15.77 | 122.84 | 34.02 | 27.85 | 21.91 | 43.05 | 31.66 | 33.19 | 29.32 | 24.13 | 37.67 | 19.87 |
| Tax % | 7.69% | -18.90% | -2.08% | 9.05% | 16.30% | 11.64% | 32.52% | 23.15% | 23.86% | 49.08% | 54.83% | 22.94% | 50.28% |
| Net Profit | 2.40 | 18.75 | 125.40 | 30.94 | 23.31 | 19.36 | 29.05 | 24.33 | 25.27 | 14.93 | 10.90 | 29.03 | 9.88 |
| EPS in Rs | 0.17 | 1.30 | 8.68 | 2.14 | 1.61 | 1.34 | 2.01 | 1.68 | 1.75 | 1.03 | 0.75 | 2.01 | 0.68 |
Last Updated: December 29, 2025, 10:34 pm
Below is a detailed analysis of the quarterly data for Mukand Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,160.62 Cr.. The value appears strong and on an upward trend. It has increased from 1,128.71 Cr. (Jun 2025) to 1,160.62 Cr., marking an increase of 31.91 Cr..
- For Expenses, as of Sep 2025, the value is 1,091.48 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,081.46 Cr. (Jun 2025) to 1,091.48 Cr., marking an increase of 10.02 Cr..
- For Operating Profit, as of Sep 2025, the value is 69.14 Cr.. The value appears strong and on an upward trend. It has increased from 47.25 Cr. (Jun 2025) to 69.14 Cr., marking an increase of 21.89 Cr..
- For OPM %, as of Sep 2025, the value is 5.96%. The value appears strong and on an upward trend. It has increased from 4.19% (Jun 2025) to 5.96%, marking an increase of 1.77%.
- For Other Income, as of Sep 2025, the value is 2.76 Cr.. The value appears to be declining and may need further review. It has decreased from 38.68 Cr. (Jun 2025) to 2.76 Cr., marking a decrease of 35.92 Cr..
- For Interest, as of Sep 2025, the value is 37.53 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 33.89 Cr. (Jun 2025) to 37.53 Cr., marking an increase of 3.64 Cr..
- For Depreciation, as of Sep 2025, the value is 14.50 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.37 Cr. (Jun 2025) to 14.50 Cr., marking an increase of 0.13 Cr..
- For Profit before tax, as of Sep 2025, the value is 19.87 Cr.. The value appears to be declining and may need further review. It has decreased from 37.67 Cr. (Jun 2025) to 19.87 Cr., marking a decrease of 17.80 Cr..
- For Tax %, as of Sep 2025, the value is 50.28%. The value appears to be increasing, which may not be favorable. It has increased from 22.94% (Jun 2025) to 50.28%, marking an increase of 27.34%.
- For Net Profit, as of Sep 2025, the value is 9.88 Cr.. The value appears to be declining and may need further review. It has decreased from 29.03 Cr. (Jun 2025) to 9.88 Cr., marking a decrease of 19.15 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.68. The value appears to be declining and may need further review. It has decreased from 2.01 (Jun 2025) to 0.68, marking a decrease of 1.33.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:57 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,516 | 3,016 | 2,953 | 2,713 | 3,436 | 3,689 | 2,923 | 2,726 | 4,643 | 5,568 | 5,175 | 4,890 | 4,658 |
| Expenses | 2,329 | 2,643 | 2,593 | 2,351 | 3,216 | 3,542 | 2,848 | 3,228 | 4,404 | 5,739 | 4,882 | 4,605 | 4,405 |
| Operating Profit | 188 | 373 | 360 | 361 | 220 | 148 | 75 | -502 | 239 | -172 | 293 | 285 | 254 |
| OPM % | 7% | 12% | 12% | 13% | 6% | 4% | 3% | -18% | 5% | -3% | 6% | 6% | 5% |
| Other Income | 16 | -7 | 12 | 45 | 1,331 | 79 | 68 | 748 | 119 | 573 | 15 | 14 | 49 |
| Interest | 254 | 276 | 293 | 294 | 473 | 327 | 364 | 332 | 161 | 177 | 131 | 130 | 137 |
| Depreciation | 68 | 76 | 77 | 72 | 158 | 58 | 75 | 69 | 45 | 52 | 50 | 51 | 55 |
| Profit before tax | -118 | 13 | 2 | 42 | 920 | -158 | -296 | -155 | 151 | 172 | 127 | 118 | 111 |
| Tax % | -28% | 12% | 280% | 127% | 11% | -27% | -19% | 32% | -17% | 0% | 18% | 36% | |
| Net Profit | -84 | 12 | -6 | -11 | 821 | -115 | -240 | -204 | 176 | 172 | 104 | 76 | 65 |
| EPS in Rs | -5.98 | 0.79 | -0.53 | -0.80 | 58.06 | -8.17 | -16.96 | -14.41 | 12.47 | 11.89 | 7.19 | 5.25 | 4.47 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -7% | 12% | 17% | 28% | 38% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 114.29% | -150.00% | -83.33% | 7563.64% | -114.01% | -108.70% | 15.00% | 186.27% | -2.27% | -39.53% | -26.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | -264.29% | 66.67% | 7646.97% | -7677.64% | 5.31% | 123.70% | 171.27% | -188.55% | -37.26% | 12.61% |
Mukand Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 11% |
| 3 Years: | 2% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 18% |
| 3 Years: | -2% |
| TTM: | -16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 34% |
| 3 Years: | 6% |
| 1 Year: | -14% |
| Return on Equity | |
|---|---|
| 10 Years: | -19% |
| 5 Years: | -28% |
| 3 Years: | -8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 11:20 am
Balance Sheet
Last Updated: December 4, 2025, 1:40 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 147 | 141 | 141 | 141 | 141 | 141 | 141 | 141 | 145 | 145 | 145 | 145 | 145 |
| Reserves | 1,726 | 1,725 | 1,714 | 173 | 938 | 774 | 529 | 321 | 522 | 709 | 760 | 805 | 813 |
| Borrowings | 2,365 | 2,621 | 2,852 | 2,979 | 2,124 | 2,575 | 2,755 | 2,076 | 2,036 | 1,505 | 1,489 | 1,559 | 1,811 |
| Other Liabilities | 1,393 | 1,376 | 1,386 | 1,181 | 1,243 | 975 | 1,034 | 699 | 822 | 819 | 636 | 1,033 | 1,007 |
| Total Liabilities | 5,632 | 5,863 | 6,093 | 4,474 | 4,447 | 4,465 | 4,460 | 3,237 | 3,524 | 3,178 | 3,030 | 3,542 | 3,776 |
| Fixed Assets | 2,500 | 2,461 | 2,429 | 693 | 562 | 505 | 516 | 447 | 484 | 488 | 452 | 539 | 506 |
| CWIP | 52 | 38 | 31 | 39 | 23 | 23 | 30 | 26 | 32 | 30 | 34 | 140 | 187 |
| Investments | 39 | 38 | 36 | 133 | 1,268 | 1,287 | 1,214 | 528 | 128 | 159 | 10 | 29 | 43 |
| Other Assets | 3,040 | 3,326 | 3,597 | 3,609 | 2,594 | 2,650 | 2,700 | 2,236 | 2,880 | 2,501 | 2,534 | 2,833 | 3,040 |
| Total Assets | 5,632 | 5,863 | 6,093 | 4,474 | 4,447 | 4,465 | 4,460 | 3,237 | 3,524 | 3,178 | 3,030 | 3,542 | 3,776 |
Below is a detailed analysis of the balance sheet data for Mukand Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 145.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 145.00 Cr..
- For Reserves, as of Sep 2025, the value is 813.00 Cr.. The value appears strong and on an upward trend. It has increased from 805.00 Cr. (Mar 2025) to 813.00 Cr., marking an increase of 8.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,811.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,559.00 Cr. (Mar 2025) to 1,811.00 Cr., marking an increase of 252.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,007.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,033.00 Cr. (Mar 2025) to 1,007.00 Cr., marking a decrease of 26.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,776.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,542.00 Cr. (Mar 2025) to 3,776.00 Cr., marking an increase of 234.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 506.00 Cr.. The value appears to be declining and may need further review. It has decreased from 539.00 Cr. (Mar 2025) to 506.00 Cr., marking a decrease of 33.00 Cr..
- For CWIP, as of Sep 2025, the value is 187.00 Cr.. The value appears strong and on an upward trend. It has increased from 140.00 Cr. (Mar 2025) to 187.00 Cr., marking an increase of 47.00 Cr..
- For Investments, as of Sep 2025, the value is 43.00 Cr.. The value appears strong and on an upward trend. It has increased from 29.00 Cr. (Mar 2025) to 43.00 Cr., marking an increase of 14.00 Cr..
- For Other Assets, as of Sep 2025, the value is 3,040.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,833.00 Cr. (Mar 2025) to 3,040.00 Cr., marking an increase of 207.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,776.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,542.00 Cr. (Mar 2025) to 3,776.00 Cr., marking an increase of 234.00 Cr..
However, the Borrowings (1,811.00 Cr.) are higher than the Reserves (813.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 186.00 | 371.00 | 358.00 | 359.00 | 218.00 | 146.00 | 73.00 | -504.00 | 237.00 | -173.00 | 292.00 | 284.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 135 | 122 | 144 | 137 | 31 | 45 | 52 | 69 | 39 | 30 | 38 | 32 |
| Inventory Days | 413 | 380 | 417 | 456 | 220 | 227 | 309 | 217 | 184 | 144 | 173 | 240 |
| Days Payable | 296 | 230 | 238 | 294 | 196 | 138 | 172 | 84 | 64 | 50 | 48 | 71 |
| Cash Conversion Cycle | 253 | 273 | 323 | 299 | 56 | 134 | 189 | 203 | 159 | 125 | 163 | 201 |
| Working Capital Days | 39 | 87 | 104 | 119 | -15 | 53 | 77 | 155 | 41 | 97 | 119 | 20 |
| ROCE % | 4% | 7% | 7% | 8% | 4% | 5% | 2% | -18% | 8% | -8% | 11% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| JM Aggressive Hybrid Fund | 124,126 | 1.98 | 2.19 | 124,126 | 2025-04-22 05:41:25 | 0% |
| JM Aggressive Hybrid Fund - Dividend | 124,126 | 1.98 | 2.19 | 124,126 | 2025-04-22 17:25:25 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.24 | 7.11 | 11.89 | 12.55 | -14.41 |
| Diluted EPS (Rs.) | 5.24 | 7.11 | 11.89 | 12.55 | -14.41 |
| Cash EPS (Rs.) | 8.76 | 10.55 | 15.96 | 15.86 | -5.79 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 65.71 | 63.74 | 59.08 | 44.15 | 32.71 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 65.71 | 63.74 | 59.08 | 44.15 | 32.71 |
| Revenue From Operations / Share (Rs.) | 338.38 | 358.09 | 385.27 | 327.86 | 192.76 |
| PBDIT / Share (Rs.) | 20.67 | 21.31 | 28.24 | 26.12 | 21.19 |
| PBIT / Share (Rs.) | 17.16 | 17.87 | 24.62 | 22.96 | 16.34 |
| PBT / Share (Rs.) | 8.19 | 8.78 | 12.37 | 11.60 | -7.16 |
| Net Profit / Share (Rs.) | 5.25 | 7.11 | 12.34 | 12.69 | -10.63 |
| NP After MI And SOA / Share (Rs.) | 5.25 | 7.11 | 11.89 | 12.55 | -14.41 |
| PBDIT Margin (%) | 6.10 | 5.95 | 7.33 | 7.96 | 10.99 |
| PBIT Margin (%) | 5.07 | 4.99 | 6.38 | 7.00 | 8.47 |
| PBT Margin (%) | 2.41 | 2.45 | 3.21 | 3.53 | -3.71 |
| Net Profit Margin (%) | 1.55 | 1.98 | 3.20 | 3.87 | -5.51 |
| NP After MI And SOA Margin (%) | 1.55 | 1.98 | 3.08 | 3.82 | -7.47 |
| Return on Networth / Equity (%) | 7.99 | 11.14 | 20.11 | 28.41 | -44.05 |
| Return on Capital Employeed (%) | 22.05 | 10.73 | 15.03 | 20.76 | 10.08 |
| Return On Assets (%) | 2.14 | 3.37 | 5.40 | 5.11 | -6.29 |
| Long Term Debt / Equity (X) | 0.10 | 1.56 | 1.69 | 1.41 | 3.80 |
| Total Debt / Equity (X) | 1.64 | 1.62 | 1.76 | 3.24 | 4.48 |
| Asset Turnover Ratio (%) | 1.48 | 1.66 | 1.69 | 1.36 | 0.68 |
| Current Ratio (X) | 1.12 | 3.72 | 3.06 | 1.44 | 2.71 |
| Quick Ratio (X) | 0.28 | 1.24 | 1.16 | 0.68 | 1.54 |
| Inventory Turnover Ratio (X) | 2.72 | 2.16 | 2.77 | 2.43 | 1.28 |
| Dividend Payout Ratio (NP) (%) | 38.08 | 28.14 | 12.61 | 7.96 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 22.82 | 18.96 | 9.66 | 6.36 | 0.00 |
| Earning Retention Ratio (%) | 61.92 | 71.86 | 87.39 | 92.04 | 0.00 |
| Cash Earning Retention Ratio (%) | 77.18 | 81.04 | 90.34 | 93.64 | 0.00 |
| Interest Coverage Ratio (X) | 2.30 | 2.34 | 2.31 | 2.30 | 0.90 |
| Interest Coverage Ratio (Post Tax) (X) | 1.59 | 1.78 | 2.01 | 2.12 | 0.54 |
| Enterprise Value (Cr.) | 2833.74 | 3583.98 | 3488.14 | 3815.98 | 3204.39 |
| EV / Net Operating Revenue (X) | 0.57 | 0.69 | 0.62 | 0.82 | 1.18 |
| EV / EBITDA (X) | 9.49 | 11.64 | 8.55 | 10.33 | 10.69 |
| MarketCap / Net Operating Revenue (X) | 0.26 | 0.41 | 0.36 | 0.43 | 0.43 |
| Retention Ratios (%) | 61.91 | 71.85 | 87.38 | 92.03 | 0.00 |
| Price / BV (X) | 1.37 | 2.33 | 2.37 | 3.19 | 2.54 |
| Price / Net Operating Revenue (X) | 0.26 | 0.41 | 0.36 | 0.43 | 0.43 |
| EarningsYield | 0.05 | 0.04 | 0.08 | 0.08 | -0.17 |
After reviewing the key financial ratios for Mukand Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.24. This value is within the healthy range. It has decreased from 7.11 (Mar 24) to 5.24, marking a decrease of 1.87.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.24. This value is within the healthy range. It has decreased from 7.11 (Mar 24) to 5.24, marking a decrease of 1.87.
- For Cash EPS (Rs.), as of Mar 25, the value is 8.76. This value is within the healthy range. It has decreased from 10.55 (Mar 24) to 8.76, marking a decrease of 1.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 65.71. It has increased from 63.74 (Mar 24) to 65.71, marking an increase of 1.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 65.71. It has increased from 63.74 (Mar 24) to 65.71, marking an increase of 1.97.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 338.38. It has decreased from 358.09 (Mar 24) to 338.38, marking a decrease of 19.71.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 20.67. This value is within the healthy range. It has decreased from 21.31 (Mar 24) to 20.67, marking a decrease of 0.64.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.16. This value is within the healthy range. It has decreased from 17.87 (Mar 24) to 17.16, marking a decrease of 0.71.
- For PBT / Share (Rs.), as of Mar 25, the value is 8.19. This value is within the healthy range. It has decreased from 8.78 (Mar 24) to 8.19, marking a decrease of 0.59.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.25. This value is within the healthy range. It has decreased from 7.11 (Mar 24) to 5.25, marking a decrease of 1.86.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.25. This value is within the healthy range. It has decreased from 7.11 (Mar 24) to 5.25, marking a decrease of 1.86.
- For PBDIT Margin (%), as of Mar 25, the value is 6.10. This value is below the healthy minimum of 10. It has increased from 5.95 (Mar 24) to 6.10, marking an increase of 0.15.
- For PBIT Margin (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 10. It has increased from 4.99 (Mar 24) to 5.07, marking an increase of 0.08.
- For PBT Margin (%), as of Mar 25, the value is 2.41. This value is below the healthy minimum of 10. It has decreased from 2.45 (Mar 24) to 2.41, marking a decrease of 0.04.
- For Net Profit Margin (%), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 5. It has decreased from 1.98 (Mar 24) to 1.55, marking a decrease of 0.43.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 8. It has decreased from 1.98 (Mar 24) to 1.55, marking a decrease of 0.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.99. This value is below the healthy minimum of 15. It has decreased from 11.14 (Mar 24) to 7.99, marking a decrease of 3.15.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.05. This value is within the healthy range. It has increased from 10.73 (Mar 24) to 22.05, marking an increase of 11.32.
- For Return On Assets (%), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 5. It has decreased from 3.37 (Mar 24) to 2.14, marking a decrease of 1.23.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 0.2. It has decreased from 1.56 (Mar 24) to 0.10, marking a decrease of 1.46.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.64. This value exceeds the healthy maximum of 1. It has increased from 1.62 (Mar 24) to 1.64, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.48. It has decreased from 1.66 (Mar 24) to 1.48, marking a decrease of 0.18.
- For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has decreased from 3.72 (Mar 24) to 1.12, marking a decrease of 2.60.
- For Quick Ratio (X), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 1. It has decreased from 1.24 (Mar 24) to 0.28, marking a decrease of 0.96.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.72. This value is below the healthy minimum of 4. It has increased from 2.16 (Mar 24) to 2.72, marking an increase of 0.56.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 38.08. This value is within the healthy range. It has increased from 28.14 (Mar 24) to 38.08, marking an increase of 9.94.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 22.82. This value is within the healthy range. It has increased from 18.96 (Mar 24) to 22.82, marking an increase of 3.86.
- For Earning Retention Ratio (%), as of Mar 25, the value is 61.92. This value is within the healthy range. It has decreased from 71.86 (Mar 24) to 61.92, marking a decrease of 9.94.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 77.18. This value exceeds the healthy maximum of 70. It has decreased from 81.04 (Mar 24) to 77.18, marking a decrease of 3.86.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.30. This value is below the healthy minimum of 3. It has decreased from 2.34 (Mar 24) to 2.30, marking a decrease of 0.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 3. It has decreased from 1.78 (Mar 24) to 1.59, marking a decrease of 0.19.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,833.74. It has decreased from 3,583.98 (Mar 24) to 2,833.74, marking a decrease of 750.24.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.69 (Mar 24) to 0.57, marking a decrease of 0.12.
- For EV / EBITDA (X), as of Mar 25, the value is 9.49. This value is within the healthy range. It has decreased from 11.64 (Mar 24) to 9.49, marking a decrease of 2.15.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 1. It has decreased from 0.41 (Mar 24) to 0.26, marking a decrease of 0.15.
- For Retention Ratios (%), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.85 (Mar 24) to 61.91, marking a decrease of 9.94.
- For Price / BV (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has decreased from 2.33 (Mar 24) to 1.37, marking a decrease of 0.96.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 1. It has decreased from 0.41 (Mar 24) to 0.26, marking a decrease of 0.15.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mukand Ltd:
- Net Profit Margin: 1.55%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.05% (Industry Average ROCE: 13.27%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.99% (Industry Average ROE: 192.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.28
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 29 (Industry average Stock P/E: 105.53)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.64
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.55%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Steel - Alloys/Special | Bajaj Bhawan, Jamnalal Bajaj Marg Mumbai Maharashtra 400021 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Niraj Bajaj | Chairman & Managing Director |
| Mr. Nirav Bajaj | Whole Time Director |
| Mr. A M Kulkarni | Non Executive Director |
| Mr. Sankaran Radhakrishnan | Independent Director |
| Mr. Prem Kumar Swamidas Chandrani | Independent Director |
| Mr. Tasneem Mehta | Independent Director |
FAQ
What is the intrinsic value of Mukand Ltd?
Mukand Ltd's intrinsic value (as of 15 January 2026) is ₹122.45 which is 5.81% lower the current market price of ₹130.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,875 Cr. market cap, FY2025-2026 high/low of ₹162/84.4, reserves of ₹813 Cr, and liabilities of ₹3,776 Cr.
What is the Market Cap of Mukand Ltd?
The Market Cap of Mukand Ltd is 1,875 Cr..
What is the current Stock Price of Mukand Ltd as on 15 January 2026?
The current stock price of Mukand Ltd as on 15 January 2026 is ₹130.
What is the High / Low of Mukand Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mukand Ltd stocks is ₹162/84.4.
What is the Stock P/E of Mukand Ltd?
The Stock P/E of Mukand Ltd is 29.0.
What is the Book Value of Mukand Ltd?
The Book Value of Mukand Ltd is 66.3.
What is the Dividend Yield of Mukand Ltd?
The Dividend Yield of Mukand Ltd is 1.54 %.
What is the ROCE of Mukand Ltd?
The ROCE of Mukand Ltd is 9.91 %.
What is the ROE of Mukand Ltd?
The ROE of Mukand Ltd is 7.84 %.
What is the Face Value of Mukand Ltd?
The Face Value of Mukand Ltd is 10.0.